POPULARITY
Categories
139 episodes with guidelines
83 episodes with guidelines
139 episodes with guidelines
82 episodes with guidelines
65 episodes with guidelines
65 episodes with guidelines
42 episodes with guidelines
86 episodes with guidelines
43 episodes with guidelines
27 episodes with guidelines
42 episodes with guidelines
36 episodes with guidelines
20 episodes with guidelines
36 episodes with guidelines
30 episodes with guidelines
34 episodes with guidelines
19 episodes with guidelines
39 episodes with guidelines
19 episodes with guidelines
66 episodes with guidelines
29 episodes with guidelines
24 episodes with guidelines
9 episodes with guidelines
25 episodes with guidelines
25 episodes with guidelines
12 episodes with guidelines
11 episodes with guidelines
20 episodes with guidelines
12 episodes with guidelines
22 episodes with guidelines
23 episodes with guidelines
45 episodes with guidelines
28 episodes with guidelines
26 episodes with guidelines
13 episodes with guidelines
14 episodes with guidelines
40 episodes with guidelines
17 episodes with guidelines
24 episodes with guidelines
27 episodes with guidelines
13 episodes with guidelines
10 episodes with guidelines
13 episodes with guidelines
13 episodes with guidelines
20 episodes with guidelines
18 episodes with guidelines
11 episodes with guidelines
12 episodes with guidelines
16 episodes with guidelines
11 episodes with guidelines
10 episodes with guidelines
14 episodes with guidelines
12 episodes with guidelines
16 episodes with guidelines
Today, we give you our discussion with Drs. Kathleen Fuchs and Tony Stringer about the Minnesota Guidelines. Kathleen and Tony have served as co-chairs of the Minnesota Update Conference Steering Committee and have been intimately involved in the process that has led to the publication of the updated training guidelines for neuropsychology. On July 1st, 2022, we released a conversation with Dr. Brad Roper on an introduction to the Minnesota Conference . That initial discussion has a lot of background about the initial conceptualization, planning, and organization of the Conference, so we suggest checking it out if you'd like more context. Show notes are available at www.NavNeuro.com/176 _________________ If you'd like to support the show, here are a few easy ways: 1) Get CE credits for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Time is running out for the seven states in the Colorado River Basin to reach a deal for managing the over-tapped river, and Ag Secretary Brooke Rollins announced the USDA is proposing changes to strengthen the stocking requirements for retailers in the SNAP Program.
The head of Illinois' public health department discusses how the state is responding to all of the changes coming from the federal government-from guidance on vaccines to taking acetaphamine. The 21st Show is Illinois' statewide weekday public radio talk show, connecting Illinois and bringing you the news, culture, and stories that matter to the 21st state. Have thoughts on the show or one of our episodes, or want to share an idea for something we should talk about? Send us an email: talk@21stshow.org. If you'd like to have your say as we're planning conversations, join our texting group! Just send the word "TALK" to (217) 803-0730. Subscribe to our podcast and hear our latest conversations. Apple Podcasts: https://podcasts.apple.com/us/podcast Spotify: https://open.spotify.com/show/6PT6pb0 Find past segments, links to our social media and more at our website: 21stshow.org.
Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 1: ILD Guidelines including: ACR/CHEST Guidelines for SSc ILD (Dr. Sindhu Johnson), ERS/EULAR Clinical Practice Guidelines (Dr. Anna-Maria Hoffman-Vold) and ILD Guideline Caveats and Concerns (Dr. Jeffrey Sparks).
THE Presentations Japan Series by Dale Carnegie Training Tokyo, Japan
Nine proven strategies executives and professionals in Japan and worldwide can use to master public speaking and influence with confidence Why do business professionals need presentation guidelines? Most of us stumble into public speaking without training. We focus on doing our jobs, not plotting a public speaking career path. Yet as careers advance, presentations to colleagues, clients, or stakeholders become unavoidable. Executives at firms like Hitachi, SoftBank, or Mitsubishi know that persuasive communication directly affects career progress and credibility. Without guidelines, many professionals waste decades avoiding public speaking. The good news? It's never too late to learn. By following proven principles, anyone can become a confident communicator capable of inspiring audiences and strengthening personal brands. Mini-Summary: Public speaking is not optional in business careers. Guidelines accelerate confidence and credibility, ensuring leaders don't miss opportunities. Should you use notes during a presentation? Yes, brief notes are acceptable. Smart presenters use them as navigation aids, either on the podium or discreetly placed behind the audience. Audiences don't penalise speakers for glancing at notes—they care about clarity and delivery. The real mistake is trying to memorise everything, which creates unnecessary stress. Professionals at companies like Goldman Sachs or Deloitte often carry structured notes to ensure flow without losing authenticity. The key is to avoid reading word-for-word and instead speak naturally to main points. Mini-Summary: Notes provide direction and reduce stress. Reading word-for-word damages authenticity, but reference notes enhance confidence. Why is reading or memorising speeches ineffective? Reading entire speeches is disengaging. Audiences quickly tune out when delivery sounds like a monotone recitation. Memorising 30 minutes of text is equally flawed—it strains memory and removes spontaneity. Modern leaders need flexibility, not rigid scripts. Instead, professionals should memorise key ideas, not sentences. Political leaders and CEOs alike rely on talking points, not full manuscripts, to stay natural and adaptable. In Japan, executives trained in Dale Carnegie programs learn to communicate with presence, not performance. Mini-Summary: Reading or memorising word-for-word suffocates engagement. Focus on key points to remain natural, flexible, and credible. How can evidence strengthen your presentation? Audiences are sceptical of sweeping statements. Without proof, leaders risk credibility damage. Evidence—statistics, expert testimony, and case studies—adds authority. A claim like “our industry is growing” has little weight unless supported with 2025 market research or benchmarks from firms like PwC or Bain & Company. In Japan's cautious corporate culture, data-backed arguments are particularly vital. Numbers, trends, and customer case studies reinforce trust, especially during Q&A sessions where credibility is tested. Mini-Summary: Evidence turns opinion into authority. Leaders should support claims with facts, statistics, and expert sources to maintain credibility. Why is rehearsal so important? Practice transforms delivery. Presenting to trusted colleagues provides feedback and confidence. But avoid asking vague questions like “What do you think?” Instead, request specifics: “What was strong?” and “How can it improve?” This reframes feedback into constructive insight. At global firms, leaders often rehearse in front of teams or communication coaches before critical investor calls or town halls. Japanese executives, known for precision, benefit greatly from structured rehearsal before presenting to boards or government stakeholders. Mini-Summary: Rehearsal reduces anxiety and strengthens delivery. Ask targeted questions to turn feedback into actionable improvement. Do you always need visual aids? Not necessarily. Slides are valuable only if they add clarity. Overloaded decks weaken impact, but visuals with people, trends, or key figures make content memorable. A simple chart highlighting one data point can be more persuasive than 20 dense slides. Visuals also act as navigation, allowing presenters to recall main points naturally. At firms like Apple or Tesla, minimalist visuals emphasise storytelling over clutter—an approach business leaders worldwide can adopt. Mini-Summary: Visual aids should clarify, not confuse. Use them sparingly to highlight key ideas and support storytelling. How should professionals control nerves before speaking? Nervous energy—“butterflies”—is natural. The solution is physical and mental preparation. Deep, slow breathing lowers heart rate and calms the body. Some professionals walk briskly backstage to burn excess energy, while others use pep talks to raise intensity. Finding a personal ritual is key. Research in workplace psychology shows that controlled breathing and physical grounding improve focus. Japanese executives presenting at high-stakes shareholder meetings often use discreet breathing exercises before stepping on stage. Mini-Summary: Anxiety is natural. Breathing, movement, and mental preparation channel nerves into productive energy. Why should you never imitate other speakers? Authenticity wins. Copying others produces inauthentic delivery and limits growth. Instead, leaders should develop their own voice through practice and feedback. Life is too short to be a poor copy of someone else. Famous communicators like Steve Jobs or Sheryl Sandberg became iconic not by imitation but by honing unique, authentic styles. The same is true in Japan: executives respected for leadership presence stand out because they are genuine. Mini-Summary: Don't copy others. Develop a natural, authentic style that reflects your personality and strengths. Conclusion: How do guidelines transform your presentation career? Public speaking is not an optional skill—it defines leadership impact. By applying nine guidelines—using notes, avoiding reading, focusing on key points, backing claims with evidence, knowing more than you say, rehearsing, using visuals wisely, controlling nerves, and being authentic—professionals protect and elevate their personal brands. Key Takeaways: Notes guide, but don't read word-for-word. Memorise ideas, not sentences. Use evidence to back claims and build authority. Rehearse with feedback for confidence. Visuals should enhance, not clutter. Control nerves with breathing and energy rituals. Authenticity beats imitation every time. Leaders at all levels should take action now: seek training, rehearse deliberately, and present with authenticity. Don't waste years avoiding public speaking. The sooner you embrace it, the faster your leadership brand grows. About the Author Dr. Greg Story, Ph.D. in Japanese Decision-Making, is President of Dale Carnegie Tokyo Training and Adjunct Professor at Griffith University. He is a two-time winner of the Dale Carnegie “One Carnegie Award” (2018, 2021) and recipient of the Griffith University Business School Outstanding Alumnus Award (2012). As a Dale Carnegie Master Trainer, Greg is certified to deliver globally across all leadership, communication, sales, and presentation programs, including Leadership Training for Results. He has written several books, including three best-sellers — Japan Business Mastery, Japan Sales Mastery, and Japan Presentations Mastery — along with Japan Leadership Mastery and How to Stop Wasting Money on Training. His works have been translated into Japanese, including Za Eigyō (ザ営業), Purezen no Tatsujin (プレゼンの達人), Torēningu de Okane o Muda ni Suru no wa Yamemashō (トレーニングでお金を無駄にするのはやめましょう), and Gendaiban “Hito o Ugokasu” Rīdā (現代版「人を動かす」リーダー). Greg also publishes daily business insights on LinkedIn, Facebook, and Twitter, and hosts six weekly podcasts. On YouTube, he produces The Cutting Edge Japan Business Show, Japan Business Mastery, and Japan's Top Business Interviews, widely followed by executives seeking success strategies in Japan.
In this conversation, Sathiya and Kyle discuss the often-taboo subject of sex within Christianity, exploring the reasons behind the fear of discussing it openly. They delve into the impact of purity culture, the importance of viewing sex as a gift from God, and the necessity of selflessness in sexual relationships. Kyle shares the origins of Kingdom Sexuality, emphasizing the need for healthy conversations about sex and the role of spouses in fostering communication. They also address challenges such as sexless marriages and offer insights on how to spice up intimacy in a biblical context. The discussion concludes with thoughts on the future of sexual conversations in the church and the importance of creating safe spaces for these discussions. Join Deep Clean Inner Circle – The Brotherhood You Need (+ get coached by Sathiya) For Less Than $2/day Know more about Kyle and Kingdom Sexuality: Access Their Website Follow Kingdom Sexuality on Instagram Listen to their Podcast Know more about Sathiya's work: Submit Your Questions (Anonymously) To Be Answered On The Podcast Get A Free Copy of The Last Relapse, Your Blueprint For Recovery Watch Sathiya on Youtube For More Content Like This Chapters: (00:00) Introduction to Kingdom Sexuality and Its Mission (03:11) The Fear of Discussing Sex in Christianity (06:07) Reconstructing a Biblical Framework for Sex (08:57) The Importance of Selflessness in Sexual Relationships (11:47) The Origins of Kingdom Sexuality (15:00) Navigating Boundaries in Conversations About Sex (27:13) Involvement of Spouses in the Podcast (30:26) Facilitating Conversations About Sex (32:49) The Role of Communication in Marriage (35:37) Guidelines for Trying New Things (39:29) Navigating Personal Convictions (42:50) Addressing a Sexless Marriage (44:48) Spicing Things Up in the Bedroom (49:58) The Role of the Church in Sexual Conversations
The JournalFeed podcast for the week of Sept 22-26, 2025.These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.Monday's Spoon Feed:Strap in for a longer-than-normal Spoon Feed to stay updated on the latest ATS guidelines for diagnosing and treating CAP.Wednesday's Spoon Feed:The 2025 AHA/ACC hypertension guidelines recommend a universal BP goal of
In this episode, I share my role as a Climate Advocate and why it matters to me. I discuss the importance of reducing our carbon footprint for the planet's well-being. I provide guidelines on how we can help and include links to websites with information on the effects of excessive CO2. A post on my Tech4boomers blog offers more details on climate change causes and websites to learn more. Listeners can also find links in this podcast description to learn more about this crucial topic. CAUSES OF CLIMATE CHANGE Source: https://www.nrdc.org/stories/what-are-causes-climate-change#humanCLIMATE CHANGE INFO FOR KIDS: https://www.natgeokids.com/uk/discover/science/nature/how-to-save-the-planet/https://kids.frontiersin.org/collections/59311/climate-change-volume-2CO2 -FYIhttps://iere.org/carbon-dioxide-an-air-pollutant/GREENHOUSE EFFECT and HEALTHhttps://iere.org/carbon-dioxide-an-air-pollutant/#The_Greenhouse_Effect_and_CO2WHAT CAN WE DO?https://scied.ucar.edu/learning-zone/climate-solutions/reduce-greenhouse-gasesFOODWASTE SOLUTIONS and COMPOSTINGhttps://scied.ucar.edu/learning-zone/climate-solutions/reduce-greenhouse-gaseshttps://www.nyc.gov/site/dsny/collection/residents/food-scrap-drop-off.pageAPPS for FoodScrap DropOffs in New Yorkhttps://apps.apple.com/us/app/nyc-compost/id1596363693https://play.google.com/store/apps/details?id=com.bigbellysolar.nycsmartcompost Westchester County Residents – Easily find and access food scrap drop off programsCompostHere on the App StoreCompostHere - Apps on Google PlayBetter Earth's Compost Drop Off Database.https://becompostable.com/sustainability/compostables-drop-off/Tech4Boomers BlogCLIMATE ADVOCATE INFORMATION & GUIDELINES | tech4boomersAll the best in Wellness! For the past several years, blogging has been both a passion and an avocation. I am engaged in exploring the therapeutic uses of essential oils, and I am also a Climate Advocate. I invite you visit my Website: JudithGuerra.com
On this episode of BloodStream, we explore the World Health Organization's updates to the Essential Medicines List and what they mean for bleeding disorders care. Hemophilia B mom and creator Jesseca Lockie shares her perspective on advocacy and storytelling online, while Domenic and his mom open up about how gene therapy has transformed his daily life. Real stories, important updates, and conversations shaping the bleeding disorders community. Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more. It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information. Show Notes: Subscribe: The BloodStream Podcast Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook BloodStream on X/Twitter BloodStream on Instagram BloodStream on LinkedIn BloodStream on TikTok
This week Sam discusses the EU's proposal to develop faster and clearer procedures to benefit the agricultural industry, yesterday's UN General Assembly on the prevention and control of non-communicable diseases, a strike in British Columbia that's affecting the wine industry, an extension on importing grapes for Canadian wine and recent statistics related to UK duty hikes. You can read the transcript of this newscast (with linked news sources) at https://www.jancisrobinson.com/articles/bc-strike-uk-duty-hike-results-un-alcohol-and-health-guidelines.
Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for the management of differentiated thyroid cancer. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor of Medicine, Department of Endocrinology, Stanford School of Medicine, Palo Alto, California Julie Ann Sosa, MD, Professor, Department of Medicine, University of California, San Francisco (UCSF) To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0
The evidence informing the changes to the new Australian Cervical Screening Program The role of cervical screening in managing symptomatic patients Some cases which present some more difficult treatment decisions such as persistent HPV in older women Host: Dr Terri Foran | Total Time:24 mins Expert: Professor Marion Saville AM, Anatomic Pathologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.
Healthcare workers across Southern California are struggling to provide medical care to undocumented patients, without clear guidance on how to handle encounters with immigration agents. Medical workers want hospitals to improve guidelines and provide better training so they can protect patients and themselves. Reporter: Anthony Victoria, KVCR A federal court hearing on whether or not roving immigration patrols can continue in the Los Angeles area has been postponed. Reporter: Wendy Fry, CalMatters A nearly seven mile stretch of Highway 1 near Big Sur will remain closed this winter, three years after back to back landslides wrecked the roadway. But things could improve in the spring. Reporter: Robert Garrova, LAist Learn more about your ad choices. Visit megaphone.fm/adchoices
The Chrisman Commentary Daily Mortgage News Podcast delivers timely insights for mortgage lenders, loan officers, capital markets professionals, and anyone curious about the mortgage and housing industry. Hosted by industry expert Robbie Chrisman, each weekday episode breaks down mortgage rates, lending news, housing market trends, capital markets activity, and regulatory updates with insightful analysis, expert perspectives, and conversations with top professionals from across the mortgage industry. Stay informed, gain actionable insights, and keep up with developments in mortgage banking and housing finance. Learn more at www.chrismancommentary.com.In today's episode, we go through MBA's latest origination figures and estimates. Plus, Robbie sits down with Guideline Buddy's Marc Hernandez for a discussion on AI-powered tools designed to bring instant clarity and confident decision-making to mortgage guidelines, helping industry professionals structure loans faster and more accurately, combining human-in-the-loop intelligence with plans for broader tech integration and white-label partnerships. And why have mortgage rates actually gone up since the Fed cut its overnight rate?This week's podcasts are sponsored by BeSmartee, the most innovative mortgage technology platform for banks, credit unions, and non-bank mortgage lenders.
Send us a textWelcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial looking at aspirin in patients with chronic coronary syndrome receiving oral anticoagulation. Here we go!Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (0:00 – 9:43).Throwback to EPIC-CAD: The Rounds Table Episode 94: Top Papers from the 2024 European Society of Cardiology Congress The Good Stuff:Trial Files is a free monthly newsletter on practice-changing trials, delivered straight to your inbox (https://trialfiles.substack.com/).Guidelines summaries coming to Trial Files soon!Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods
This episode covers: Cardiology This Week: A concise summary of recent studies Strategic decisions in valvular heart disease Optimising drug therapy in chronic coronary syndromes Mythbusters: Does wearing a white coat make you smarter? Host: Susanna Price Guests: John-Paul Carpenter, Fabien Praz, Robert Storey Want to watch that episode? Go to: https://esc365.escardio.org/event/2092 Want to watch that extended interview on Optimising drug therapy in chronic coronary syndromes ? Go to: https://esc365.escardio.org/event/2092?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Fabien Praz and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Robert Storey has declared to have potential conflicts of interest to report: research grants and personal fees from AstraZeneca and Cytosorbents, and personal fees from Abbott, Afortiori Development/Thrombolytic Science, Boehringer Ingelheim/Lilly, Bristol Myers Squibb/Johnson & Johnson, Chiesi, Idorsia/Viatris, Novo Nordisk, PhaseBio and Tabuk. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Alex ist 21 und verdient als Only-Fans-Manager nach eigenen Angaben sechsstellig im Jahr. Sein Geschäftsmodell: Er managt Only-Fans-Models und beschäftigt "Chatter". Also Menschen, die im Namen der Frauen mit ihren Fans schreiben, flirten und intime Inhalte verkaufen. Für die Kundinnen und Kunden soll sich das echt anfühlen. Dabei baut Alex Business eigentlich auf Täuschung auf. Y-Kollektiv-Reporter Leon Hüttel will verstehen, wie dieses System funktioniert. Dafür trifft er Alex in seinem Kinderzimmer-Office. Da, wo Alex sein Business gestartet hat. Leon bekommt Einblick in interne Guidelines und lernt wie man Kunden auf Only Fans emotional an sich bindet. Viele wissen nicht, dass sie statt mit Models mit Chattern sprechen. Wir bekommen einen exklusiven Einblick in private Chats, die zeigen: Viele der Kundinnen und Kunden haben enge Kontakte mit den Models, teilen ihren Alltag und Probleme. Und es bleibt die Frage: Wie vertretbar ist ein System, das Nähe nur inszeniert? Reporter: Leon Hüttel Redaktion: Pamina Rosenthal Technische Produktion: Adrian Eichmann, Eva Garthe Unser aktueller Podcast Tipp: "Wissen mit Johnny" https://1.ard.de/Wissenmitjohnny "Y-Kollektiv – Der Podcast" wird verantwortet von Radio Bremen und dem rbb. Diese Episode ist eine Produktion von Radio Bremen 2025. Habt ihr Feedback oder Kritik? Schreibt uns gerne an y-podcast@ard.de oder www.instagram.com/y_kollektiv/
Charitable giving is a cornerstone of many comprehensive retirement plans. It's also a cornerstone of our mission at Keen Wealth Advisors. Our whole team takes great pride in serving as active members of our community, whether we're making monetary grants or lending a hand to projects around the greater Kansas City area. And through the efforts of the Keen Wealth Foundation, we're able to identify causes where we can have a high impact and share what we've learned about effective giving with friends and clients of the firm. On today's show, I'm honored to welcome the director of the Keen Wealth Foundation, my wife Carissa Keen, to discuss our philanthropic mission. Carissa also shares some best practices and a checklist that can help you feel more confident as you evaluate and consider which charitable causes and organizations you may want to support.
Listen or watch along as we dive into updates on axial spondyloarthritis (axSpA) treatments and 'The 2025 British Society for Rheumatology guideline for treatment of axial Spondyloarthritis with biologic and targeted synthetic DMARDs'.In this episode, podcast host Mel Brooke, BIRDs Patient and Public Engagement Programme talks with Professor Raj Sengupta, Consultant rheumatologist and Lead Consultant for Axial Spondyloarthritis at the RNHRD, RUH Bath about changes to axSpA treatments since our first series in 2020. Useful Links:BSR GuidelineNational Axial Spondyloarthritis SocietyInhealthcare Connect further with us:Have questions or thoughts about our information Podcast library? Interested in joining BIRDs patient research panel? Email Mel at ppe@birdbath.org.ukBe sure to subscribe, rate, and review the podcast to help us continue sharing information that matters!Thank you to all our sponsors for helping us to bring you information that supports you and helps to increase your knowledge of rheumatic diseases.Please visit the BIRD website to sign up for news.
Listen or watch along as we dive into updates on axial spondyloarthritis (axSpA) treatments and 'The 2025 British Society for Rheumatology guideline for treatment of axial Spondyloarthritis with biologic and targeted synthetic DMARDs'.In this episode, podcast host Mel Brooke, BIRDs Patient and Public Engagement Programme talks with Professor Raj Sengupta, Consultant rheumatologist and Lead Consultant for Axial Spondyloarthritis at the RNHRD, RUH Bath about changes to axSpA treatments since our first series in 2020. Useful Links:BSR GuidelineNational Axial Spondyloarthritis SocietyInhealthcare Connect further with us:Have questions or thoughts about our information Podcast library? Interested in joining BIRDs patient research panel? Email Mel at ppe@birdbath.org.ukBe sure to subscribe, rate, and review the podcast to help us continue sharing information that matters!Thank you to all our sponsors for helping us to bring you information that supports you and helps to increase your knowledge of rheumatic diseases.Please visit the BIRD website to sign up for news.
09-23-25 - Happy Morning For John Following Another Ravens Loss On MNF - Trump Announces Guidelines For Pregnant Women Taking Acetaminophen - Has The Rapture Started Since We're 16 Hours BehindSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The Trump administration continues to question long-standing science with unproven ties between vaccines, autism, and a popular painkiller. Meantime, the Centers for Disease Control and Prevention has outlined new recommendations for vaccines. We'll sort it out with CPR's health reporter John Daley. Then, new research looks at if activities, like the way we drive, could be an early indicator Alzheimer's and other types of dementia.
Send us a textIn this episode of PT Snacks podcast, we dive deep into scaphoid fractures, a common yet often mismanaged injury in younger and active individuals. Listeners will learn about the anatomy of the scaphoid bone, the typical mechanisms of injury, common diagnostic challenges, and both conservative and surgical treatment options. We explain the importance of recognizing and adequately managing these fractures to prevent complications like avascular necrosis and non-union. Tune in to enhance your knowledge and clinical skills regarding this significant topic in physical therapy.00:00 Introduction and Welcome00:44 Topic Overview: Scaphoid Fractures01:21 Anatomy of the Scaphoid03:29 Mechanisms and Risk Factors04:27 Diagnosis and Imaging05:11 Differential Diagnosis05:59 Symptoms and Clinical Examination06:36 Treatment Options07:40 Conclusion and Additional ResourcesReferencesSteinmann S, et al. Scaphoid fractures and nonunions: diagnosis and treatment. J Orthop Sci. 2006.Rhemrev S, et al. Current methods of diagnosis and treatment of scaphoid fractures. Int J Emerg Med. 2011.Clementson M, et al. Acute scaphoid fractures: guidelines for diagnosis and treatment. EFORT Open Rev. 2020.Krasin E, et al. Review of the current methods in the diagnosis and treatment of scaphoid fractures. Postgrad Med J. 2001.Krimmer H, et al. [Scaphoid fractures—diagnosis, classification and therapy]. Unfallchirurg. 2000.Clementson M, et al. [Scaphoid fractures – Guidelines for diagnosis and treatment]. Lakartidningen. 2019.Pickrell BB, et al. Update on management of scaphoid fractures. Plast Reconstr Surg. 2024.Go to PT Final Exam using this link to access great studying options to conquer the NPTE!Support the showStay Connected! Make sure to hit follow now so you don't miss an episode! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. You can also join the email list HERE Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less! Prepping for the NPTE? Get all the study tools you need to master it at PT Final Exam. Use code PTSnacks at checkout to get a discount! Want to Support the Show?Help me keep creating free content by: Sharing the podcast with someone who'd benefit. Contributing directly via the link...
09-23-25 - Happy Morning For John Following Another Ravens Loss On MNF - Trump Announces Guidelines For Pregnant Women Taking Acetaminophen - Has The Rapture Started Since We're 16 Hours BehindSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, host Sandy Vance sits with Jon Shreve, CEO of MCG, to explore how artificial intelligence is reshaping the future of clinical guidelines and decision support. They discuss how MCG is leveraging AI to strengthen its offerings for payer organizations and stakeholders across the healthcare spectrum, why consistent interpretation of guidelines is critical, and how trust plays a central role in the process. The conversation also dives into the question of whether AI standards will ever be unified and gives a sneak peek into the exciting new directions MCG is heading.In this episode, they talk about:How healthcare AI is transforming clinical guidelines and MCG's approachClinical decision support solutions for payers and healthcare organizationsWhy consistent guideline interpretation matters in healthcareBuilding trust in AI-powered clinical decision-makingWill AI standards in healthcare ever be unified?Future innovations in clinical decision support at MCGA Little About Jon:Mr. Shreve oversees all facets of MCG Health's growth and management. He was Chairman of MCG from 2002 to 2009 and became its CEO in 2007. In 2018, Glassdoor recognized him as one of the Top 50 CEOs for Medium and Small Businesses. In 2024, Glassdoor also named MCG a Best Place to Work. Under his leadership, MCG has grown by over 20x. Before MCG's acquisition by Hearst in 2012, Mr. Shreve had been with Milliman for over 25 years as an Equity Principal and Consulting Actuary. In addition to MCG, Mr. Shreve led or sponsored twenty other practices and was on Milliman's Board of Directors. Mr. Shreve received his Bachelor of Arts with distinction in Mathematics from Carleton College in Minnesota, and he is a Fellow of the Society of Actuaries, as well as a Member of the American Academy of Actuaries.
Illinois joins more than a dozen states that, in response to federal changes regarding the distribution guidelines of vaccines, is directing their public health departments to establish their own guidelines. Capitol News Illinois reporter Peter Hancock discusses those changes and how the state of Illinois aims to create a safe and clear path for those looking to get themselves and their families vaccinated.
About this Episode Episode 49 of “The 2 View” – New IDSA Complicated UTI Guidelines, Pediatric Nicotine OD, Hepatitis C Screening in the ED, High-Risk Delta Troponins Segment 1A – Pediatric Nicotine Ingestion Madelyn O, Hays HL, Kistamgari S, et al. Nicotine Ingestions Among Young Children: 2010–2023. Pediatrics. 2025;156(2):e2024070522. doi:10.1542/peds.2024-070522. Segment 1B – Finger Thoracostomy and Traumatic Pneumothorax/Hemothorax Blank, J, de Moya MA. Traumatic pneumothorax and hemothorax: What you need to know. J Trauma Acute Care Surg. Published online July 3, 2025. doi:10.1097/TA.0000000000004692 Beyer CA, Ruf AC, Alshawi AB, Cannon JW. Management of traumatic pneumothorax and hemothorax. Curr Probl Surg. 2025;63. doi:10.1016/j.cpsurg.2024.101707. Weingart, S. EMCrit 62 – Needle vs. Knife II: Needle Thoracostomy (Decompression)? EMCrit. Published online December 11, 2011. https://emcrit.org/emcrit/needle-finger-thoracostomy/ Lange C, Sharma M. Podcast #223 - ATLS Episode 4: Thoracic Trauma (Chapter 4). Total EM. October 27, 2020. https://www.totalem.org/emergency-professionals/podcast-223-atls-episode-4-thoracic-trauma-chapter-4 Segment 2A – Hepatitis C Screening in EDs Haukoos J, Rothman RE, Galbraith JW, et al. Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial. JAMA. 2025;334(6):497–507. doi:10.1001/jama.2025.10563 Segment 2B – Serial HS-Troponin Patterns Huggins C, Saltarell Ni, Swoboda TK, et al. Kinetic changes in high-sensitivity cardiac troponin for risk stratification of emergency department chest pain patients. Am J Emerg Med. 2025;93:176-181. doi:10.1016/j.ajem.2025.04.010. Segment 3 - Updated IDSA Guidelines on Complicated Urinary Tract Infections Splete H. IDSA Updates Guidelines on Complicated UTIS. Medscape. Published online July 18, 2025. https://www.medscape.com/viewarticle/idsa-updates-guidelines-complicated-utis-2025a1000j3l Trautner BW, Cortes-Penfield NW, Gupta K, et al. Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management. IDSA. Published online July 17, 2025. https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/ Roberts M, Sharma M. 34 - Pertussis, Computer Interpretation of EKGs, Tuberculosis, Fluoroquinolone Side Effects. The 2 View. Published online April 10, 2024. https://2view.fireside.fm/34 Roberts M, Sharma M. 46 - Heat Stroke Tx, A New Virus, Oral Cephalosporins Vs Pyelo, Safe Discharges. The 2 View. Published online June 11, 2025. https://2view.fireside.fm/46 Bonus Reference – Ponytail Headache Blau JN. Ponytail Headache: A Pure Extracranial Headache. Headache. 2004;44(5):411-413. doi: 10.1111/j.1526-4610.2004.04092.x. Recurring Sources Center for Medical Education. http://ccme.org The Proceduralist. http://www.theproceduralist.org The Procedural Pause. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. http://www.thesgem.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to.
Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease, is a rare, progressive neuromuscular disorder that is often misdiagnosed and diagnosed late. A new CMAJ guideline offers Canadian-specific recommendations for its recognition and management.On this episode we hear from Richard Paul, a former bus driver from Saskatoon, who recalls how his symptoms began suddenly with an inability to bite into a sandwich and, over the years, progressed so gradually he barely noticed the loss of strength. His experience captures both the slow, inexorable progression of SBMA and the uncertainty of living without a diagnosis for decades.Mr. Paul was finally diagnosed by Dr. Kerri Schellenberg, a neuromuscular neurologist at the University of Saskatchewan and lead author of the guideline. She explains the clinical hallmarks of SBMA, its overlap with conditions such as ALS, and the non-motor manifestations that require attention. She also discusses the higher prevalence among Indigenous populations in Canada and how her team worked with a community Guiding Circle to ensure the recommendations reflect culturally appropriate care.For physicians, the guideline provides practical direction to support earlier recognition, timely referral, and multidisciplinary management. While there is no cure, coordinated care can significantly improve quality of life for people living with SBMA.For more information from our sponsor, go to md.ca/md-differenceComments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions
Istrouma Baptist Church (ASC) Sep 21, 2025 ========== September 21 - Field Guide Welcome! We're glad you've joined us today for our Sunday morning worship service! For more information about Istrouma, go to istrouma.org or contact us at info@istrouma.org. We glorify God by making disciples of all nations. ========== Connection Card https://istrouma.org/myinfo Guidelines for a Healthy Church 1 Timothy 5:1-8 & 17-19 1 Timothy 5:1-19 Do not rebuke an older man but encourage him as you would a father, younger men as brothers, older women as mothers, younger women as sisters, in all purity. Honor widows who are truly widows. But if a widow has children or grandchildren, let them first learn to show godliness to their own household and to make some return to their parents, for this is pleasing in the sight of God. She who is truly a widow, left all alone, has set her hope on God and continues in supplications and prayers night and day, but she who is self-indulgent is dead even while she lives. Command these things as well, so that they may be without reproach. But if anyone does not provide for his relatives, and especially for members of his household, he has denied the faith and is worse than an unbeliever. Let a widow be enrolled if she is not less than sixty years of age, having been the wife of one husband, and having a reputation for good works: if she has brought up children, has shown hospitality, has washed the feet of the saints, has cared for the afflicted, and has devoted herself to every good work. But refuse to enroll younger widows, for when their passions draw them away from Christ, they desire to marry and so incur condemnation for having abandoned their former faith. Besides that, they learn to be idlers, going about from house to house, and not only idlers, but also gossips and busybodies, saying what they should not. So I would have younger widows marry, bear children, manage their households, and give the adversary no occasion for slander. For some have already strayed after Satan. If any believing woman has relatives who are widows, let her care for them. Let the church not be burdened, so that it may care for those who are truly widows. Let the elders who rule well be considered worthy of double honor, especially those who labor in preaching and teaching. For the Scripture says, “You shall not muzzle an ox when it treads out the grain,” and, “The laborer deserves his wages.” Do not admit a charge against an elder except on the evidence of two or three witnesses. 1. A healthy church should be characterized by respect for all. 2. A healthy church should be characterized by compassionate care for widows. 3. A healthy church should be characterized by generous provision and diligent protection of their leaders.
In this episode, the Cru dives into the world of submissions: the grind of rejection slips; the rare joy of a personal note from the editor; the endless predawn hours of "why did I have to fall in love with writing;" and the importance of READING THE DANG GUIDELINES when sending your work to literary magazines. We swap insights on what editors look for, how to handle feedback, and the value of old-fashioned gumption.Stories this week begin around the 31:30 mark (yeah, we packing in a LOT of information about submissions) and range from cosmic tragedy to intimate loss: a plane serenaded by the song of regurgitation; a quiet reckoning beneath a sky that fades to black; and a love realized only in retrospect.Like this weeks episode and wish you could read as well as listen? Subscribe to our Substack for a summary of our opening discussion, a story from the episode, and a writing prompt! Be sure to follow us on Instagram (if that's your sort of thing). Please do send us an email with your story if you write along, which we hope you will do. Episodes of Radio FreeWrite are protected by a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license. All Stories remain the property of their respective authors.
Happy September! This month for the September 2025 episode of the RCEM Learning Podcast Andy and Dave are talking about AI interpretation of ECG findings and managing acute asthma exacerbations. We are then going back to Becky and Chris rounding off the second part of their guideline on atrial fibrillation. We'll then end with New Online. If you'd like to email us, please feel free to do so here. After listening, complete a short quiz to have your time accredited for CPD at the RCEMLearning website! (02:13) New in EM - AI vs doctor in cath lab activations Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio) (Shroyer et al., 2025) (18:00) Guidelines for EM - ESC Atrial Fibrillation (Part Two) ESC - 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) (ESC, 2024) (39:03) New in EM - Management of acute asthma exacerbations As-Needed Albuterol–Budesonide in Mild Asthma (LaForce et al., 2025) Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma (Cochrane Library, 2021) (54:00) New Online – new articles on RCEMLearning for your CPD Understanding Medical Cannabis: Mechanisms, Indications and Clinical Integration - David Tang Safe Sedation Procedures in Adults - Duncan Russell and Shobhan B Thakore Unusual Agitation in Final Year Student - Cathy Wield and Mark Horowitz
Beijing has released a white paper on the successful practice of the Communist Party of China's strategy for governing Xinjiang in the new era. The document comes as the northwestern autonomous region is marking its 70th founding anniversary.
Trout Lines And Guidelines! Is it time to put a slot on the speckled trout? Tune in and see what Florida's charter captains have to say. Let's discuss! Do you have a question about fishing in your area? Email rick@floridasportsman.com and we'll answer your questions on the air. Outline of Episode 310 [1:59] Tropics Report [4:07] Northeast Report [11:25] East Central Report [18:02] South Report [24:22] 10,000 Islands Report [34:00] Southwest Report [37:00] West Central Report [45:33] Big Bend Report [55:29] Panhandle Report [59:48] Florida Wrap-Up A BIG thanks to each of our sponsors, without whom we would not be able to bring you these reports each week Yamaha Outboards • Shimano Fishing • Tournament Master Chum • D.O.A. Lures • Fishing Nosara / Nosara Paradise Rentals • Young Boats
Have you had symptoms return after stopping Lyme treatment? Share your story below. Your experience may help someone else navigating the same difficult decision.SummaryOne of the most frequent questions in Lyme care is: “If I feel better, should I stop treatment?” The answer is complicated. While no one wants to stay on antibiotics longer than necessary, stopping too soon often leads to relapse.Lyme disease is not a typical infection. Borrelia burgdorferi can persist by hiding in tissues, forming biofilms, and shifting into alternate forms. When treatment ends prematurely, surviving bacteria may re-emerge, and symptoms such as brain fog, joint pain, fatigue, or neuropathy often return. Co-infections like Babesia or Bartonella add another layer, sometimes becoming more obvious once Lyme therapy is withdrawn.Guidelines remain divided. IDSA discourages extended therapy, while ILADS—where I helped author the 2004 and 2014 guidelines—supports individualized, carefully monitored treatment when patients remain ill. The key is shared decision-making, weighing risks and benefits, and avoiding a one-size-fits-all approach.The goal is not indefinite treatment, but the minimum effective therapy that allows patients to heal and reclaim their lives. The takeaway is simple: stopping Lyme treatment too soon often means starting over. Recovery is about staying better tomorrow—not just feeling better today.
Dr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the management of antineoplastic extravasation. They discuss recommendations from the expert panel on: management of extravasation of vesicant or irritant with vesicant properties antineoplastic agents, management of extravasation of paclitaxel or docetaxel, use & duration of thermal compress, and escalation of care. They share the importance of this comprehensive interdisciplinary guideline, highlight the algorithm as a useful tool for clinicians, and outline the outstanding questions related to the management of extravasation. Read the full guideline, “ONS/ASCO Guideline on the Management of Antineoplastic Extravasation” at www.asco.org/supportive-care-guidelines TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice, https://ascopubs.org/doi/10.1200/OP-25-00579 Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Tanya Thomas, clinical chair of the guideline and clinical nurse specialist from University of Virginia Health, and Dr. Aparna Jotwani, medical oncologist from Baylor College of Medicine, authors on "Management of Antineoplastic Extravasation: Oncology Nursing Society – American Society of Clinical Oncology Guideline." Thank you for being here today, Dr. Thomas and Dr. Jotwani. Dr. Aparna Jotwani: Thank you. Dr. Tanya Thomas: Thank you for having us. Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Thomas and Dr. Jotwani, who have joined us here today, are available online with the publication of the guideline in JCO Oncology Practice, which is linked in the show notes. So then to dive into the content here, Dr. Thomas, could you start us off by providing an overview of both the scope and the objectives of this guideline? Dr. Tanya Thomas: Yes, so the objective of this guideline is to provide the evidence-based recommendations to help support our interdisciplinary teams, including the oncologist, the advanced practice providers, pharmacists, and nurses who are involved in the care and management of patients who are experiencing an extravasation of an antineoplastic agent. While rare, the antineoplastic and certain chemotherapy extravasations are oncologic emergencies. The recommendations are to minimize negative consequences and provide a standardized approach to the care when such an event occurs. Dr. Aparna Jotwani: I would add that our scope is limited to intravenous antineoplastic vesicants, irritants, and irritants with vesicant potential. The scope of the guideline applies to the care team for adult oncology patients receiving treatments through venous access. Outside the scope is management of extravasation during other routes of treatment administration, such as intraperitoneal, intravesical, and hepatic arterial infusion. Our recommendations regarding vascular access for therapy or interventions to prevent extravasations are also outside of the scope for this guideline. Brittany Harvey: Understood. I appreciate that background and understanding what's in scope and what's out of scope for this guideline. So then I'd like to pivot and talk about the key recommendations of this guideline across the clinical questions. So first, Dr. Jotwani, what does the panel recommend for patients with extravasation of vesicant or irritant with vesicant properties antineoplastic agents? Dr. Aparna Jotwani: The panel strongly recommends for all classes where an antidote exists to proceed with using the antidote. Recommendations for paclitaxel and docetaxel are specifically addressed in a recommendation. This is further detailed in Tables 1 and 4 within the guideline. Evidence on the use of antidotes for extravasation is limited to nonrandomized, uncontrolled, observational studies and case series. Placebo-controlled trials on this topic would be unethical. There is also a lack of comparative data for different antidote strategies. However, potential benefits of using the antidotes include tissue preservation and avoiding tissue necrosis. In developing the guidelines, we had an in-person roundtable discussion and weighed risks and benefits to ensure patient safety above all else. Brittany Harvey: I appreciate that description of the recommendation here. So then you just mentioned that there's a specific recommendation for paclitaxel and docetaxel. So what is recommended for those patients with extravasation of paclitaxel or docetaxel? Dr. Aparna Jotwani: So here, we conditionally recommended the specific use of hyaluronidase as the antidote. This was based on five studies that all used hyaluronidase as an antidote to lower the risk of tissue necrosis. In the studies included, with a subgroup of patients that experienced taxane-related extravasation, development of necrosis ranged from 0% to 0.83% among the patients who received an antidote. The potential harms associated with this were likely trivial. Brittany Harvey: Thank you for providing that recommendation as well. So then the next section of the guideline, Dr. Thomas, what does the expert panel recommend for use and duration of thermal compress? Dr. Tanya Thomas: So the expert panel actually recommends the use of thermal compresses, and the recommendations are based on the available literature for the various agents and the actual time frames most frequently used for the compress application. The utilization of a thermal compress is recommended for 15 to 20 minutes at a time for 3 to 4 times daily, at least for the first 48 to 72 hours after that extravasation occurs. The actual frequency and duration may vary based on the extent of the extravasation and the agent involved in that extravasation. The intent of the warm compress is to help disperse the agent and reduce the localized accumulation of the agent, whereas the cold compress, it actually helps prevent the dispersion or the spread of the agent while allowing the antidote to help neutralize that agent. Warm compresses are recommended for extravasations involving the vinca alkaloids, etoposide, oxaliplatin, and the taxanes - paclitaxel and docetaxel - only when coadministering the antidote hyaluronidase. The use of a cold compress is actually recommended for extravasations involving the anthracyclines, antimetabolites, alkylating agents, and taxanes when coadministration of the antidote hyaluronidase does not occur. Brittany Harvey: Understood. Those specific and actionable recommendations are really key for clinical practice. So then, following those recommendations, how does the guideline address escalation of care and surgical referral for patients with central line extravasation? Dr. Tanya Thomas: So this topic actually had a lot of discussion. And while there is not enough evidence to make strong recommendations, the expert panel recognized that surgical referrals should be considered in certain scenarios. Dr. Aparna Jotwani: We discussed that certain scenarios would include high-risk populations, such as patients that are receiving DNA-binding vesicants, those with high-volume estimated extravasation, and those with CTCAE grade 2, which would be erythema associated with symptoms such as edema, pain, induration, and phlebitis, or grade 3, which would be symptoms of ulceration or necrosis or concern for severe tissue damage, or grade 4, where you would have a life-threatening consequence extravasation, may have a greater likelihood of benefiting from surgical referral and/or escalation of care as deemed appropriate. Brittany Harvey: Great. And yes, it's really important to provide all of these recommendations that you've both just gone through, even when we're faced with very low evidence. So then, Dr. Thomas, in your view, what is the importance of this guideline, and how will it impact clinical practice? Dr. Tanya Thomas: So when extravasations occur in the clinical setting, members of the interdisciplinary team can be faced with barriers related to where to look for the information, how to find all the relevant information in one concise place, how to provide education to the patient about how to care for the site of extravasation in the home setting, and also when to escalate to specialized teams. This can actually cause some added stress and anxiety, and in certain circumstances, may lead to delays in efficient management. This guideline provides the resource clinicians have been looking for. It includes comprehensive recommendations for antineoplastic extravasations in one guideline while also providing a one-page algorithm with the key information regarding the management of the extravasations. This allows all levels of providers to have evidence-based recommendations regarding initial management of the extravasation, for instance, how to manage the infusion, key site assessment reminders, available antidotes, and the use of thermal compress; the required documentation, recommended follow-up scheduling, in addition to key aspects of the patient education. This type of guidance is not found in any other single document regarding antineoplastic extravasation. Having this document readily available at the point of care potentially can reduce time required for providers to search for management recommendations and also provide consistency in patient education and follow-up management scheduling. It reduces uncertainty within interdisciplinary teams and can help inform policy development for clinicians to approach extravasations with confidence. Brittany Harvey: Absolutely. I agree that this is an incredible resource for clinicians with the recommendations, the algorithm that you mentioned, and the supporting evidence that underpins these recommendations to really provide both efficient and effective care for patients. So beyond the impact for clinical practice, Dr. Jotwani, how will these guideline recommendations affect patients receiving antineoplastic treatment for cancer? Dr. Aparna Jotwani: Exactly. In addition to the clinical care team, we want to help and benefit our patients. So, oncology patients that experience extravasations are at risk for, aside of the side effects of tissue necrosis and infection, they also are at risk for delay of cancer treatment. In making these guidelines, we kept in mind the cost and the efforts for patients, additional visits that they could incur, additional time and supplies for care of the extravasation, as well as cost. Our guideline aims to provide an evidence-based approach to the care of oncology patients receiving antineoplastic intravenous therapy. While there are gaps in the data due to the nature of these events, based on careful literature review, these guidelines serve as a basis for quality, standardized oncology care during extravasation. Personally, I hope our graphics especially can be used across the systems to guide clinical care. Brittany Harvey: Definitely. We hope that these recommendations improve treatment and treatment outcomes for all patients receiving antineoplastic treatment for cancer. So then you've also just mentioned some gaps in the literature. So Dr. Thomas, I'd like to turn to you to wrap us up and ask, what are the outstanding questions for the management of antineoplastic extravasation? Dr. Tanya Thomas: Yes, that's a good question. Two of the main outstanding questions are related to the management of extravasations involving the novel agents and extravasations involving multi-agent regimens. The current literature regarding how to effectively manage the multi-agent regimens, for instance, there is no clear guidance for managing the extravasation for someone who is receiving a regimen that involves simultaneous administration of, let's say, a vinca alkaloid and an anthracycline. One of those agents requires a warm compress while the other requires a cold compress, and there are different antidotes for those two agents. Additionally, there has not been a lot of published information on the impact of extravasation of those novel agents like the antibody-drug conjugates. With the pace of the drug development, a subgroup of the guideline panelists actually are exploring case reports specific to novel agents to help inform some future work. Brittany Harvey: Yes, we'll look forward to learning more about how to address these ongoing issues and potentially impact guideline recommendations in the future as well. So I want to thank you both so much for your work to develop this incredibly important guideline, and thank you for your time today, Dr. Thomas and Dr. Jotwani. Dr. Aparna Jotwani: Thank you for the opportunity. Dr. Tanya Thomas: Yes, thank you. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. I also encourage you to check out the companion episode on this guideline on the ONS podcast, available on Amazon Music, Apple Podcasts, Spotify, and YouTube Music. And finally, you can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you've enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
HIGHLY RECOMMENDED CPD for all Dental professionals - without getting bored! Do you know exactly what to do if a patient faints in your chair? Could you spot the early signs of anaphylaxis—before it's too late? How quickly could you find and deliver adrenaline if it really mattered? https://youtu.be/7b2oG4g12q0 Watch PDP241 on Youtube After six years of podcasting and creating CPD, we're finally tackling medical emergencies the Protrusive way. In this two-part series, Jaz is joined by lead nurse and medical emergencies educator Rachel King Harris, who breaks down the real-life scenarios every dental team needs to prepare for—without the fluff or generic lecture feel. From vasovagal syncope to adrenaline protocols, you'll learn how to stay calm, think clearly, and take action when it matters most. By the end of this episode (and the next), you'll not only tick the box for your GDC-required CPD—you'll actually feel ready. Because when emergencies happen in the chair, panic isn't a plan. Let's get you prepared. Protrusive Dental Pearl: Be emergency-ready! Download a free medical emergencies cheat sheet — a quick guide for symptoms, drugs, and actions during a crisis. You can download this ready-made cheat sheet for free at protrusive.co.uk/me. Print it, laminate it, and pop it into your medical kit. Your whole team will thank you! Key Takeaways: Medical emergencies in dentistry are rare but high-stakes — being prepared is essential. Guidelines change often — regular refreshers are vital. You don't need to memorise everything — use validated resources and calm judgment. Vasovagal Syncope is the most common emergency in dental settings. If unconsciousness persists → consider other causes: meds, blood sugar, cardiac issues. Anaphylaxis can occur even without rash — don't wait for it. Key signs: stridor, lip/tongue swelling, wheeze, “impending doom,” difficulty breathing. Keep emergency drug guides visible and updated (e.g., BDA laminated sheets). Ampules = longer shelf life, more doses than EpiPens, and more cost-effective. Don't wait for the rash — airway signs matter most in anaphylaxis. Always carry two adrenaline auto-injectors — even for mild allergy patients. Highlights of this episode: 00:00 TEASER 00:53 INTRO 04:50 Protrusive Dental Pearl 06:01 Meet Rachel King Harris: Expert in Medical emergencies 09:42 Practical Tips for Emergencies 12:05 Understanding Vasavagal Syncope 17:01 GTN Spray 20:09 Recognizing and managing Anaphylaxis 30:05 Midroll 33:26 Recognizing and managing Anaphylaxis 34:41 Allergic Reaction to Chlorhexidine Gel 37:27 What's Inside Emergency Bag? 41:51 Adrenaline Ampules vs Auto-Injectors 52:04 Oxygen Administration In Dental Practices 57:13 Oxygen and Emergency tools 59:05 Oxygen Contraindication 1:06:37 Outro Stay up to date by reviewing the latest guidelines from the Resuscitation Council UK. Check out this Anaphylaxis Summary Document Enjoyed this one? Make sure to check out PDP159 – How to Manage Children in Dental Pain, where we dive into real-life paediatric emergencies in dentistry. This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance. This episode meets GDC Outcomes C and D. AGD Subject Code: 142 Medical emergency training and CPR Aim:To improve the preparedness and confidence of dental professionals in recognising and managing common medical emergencies in the dental setting, with an emphasis on vasovagal syncope, anaphylaxis, and appropriate use of emergency medications and equipment. Dentists will be able to - Identify early signs and symptoms of vasovagal syncope and anaphylaxis in a dental setting. Apply appropriate first-aid management protocols, including patient positioning, airway support, and oxygen delivery. Understand the updated guidelines for prioritising adrenaline over antihistamines or steroids in ana...
Tim Peters, CMO of Guideline, discusses his 25-year journey from startup founder to marketing executive at public companies. He reveals how his company collects $150B in real advertising spend data from major brands and uses AI to provide actionable insights for marketing strategy, competitive analysis, and campaign optimization across different business stages.00:35- About Tim PetersTim is the CMO of Guideline.ai.He's an advisor to multiple VC funds, and has built and exited several ventures across tech, media and nonprofit centers.
Cardiovascular expert Colleen Walsh-Irwin returns to NP Pulse for an in-depth look at hyperlipidemia and the importance of controlling LDL-C levels. Walsh-Irwin also walks us through lipid panels, risk scoring and the many tools NPs have at their disposal to keep patients healthy and informed. This podcast is made possible by Amgen.
Don't wait for a crisis to seek God—now is the moment of His favor, today is the day of salvation.
Australia's eSafety commissioner has published regulatory guidelines for social media platforms, giving effect to the government's under-16 social media ban. While the ban won't be in place until December 10th, the eSafety commissioner says they want it to be as minimally invasive as possible. Under the guidance, social media platforms will not have to verify the age of every user on their platforms. - 16歳以下の未成年を対象としたSNS利用規制の開始を前に、規制ガイドラインが発表されました。
Australia's eSafety commissioner has published regulatory guidelines for social media platforms, giving effect to the government's under-16 social media ban. While the ban won't be in place until December 10th, the eSafety commissioner says they want it to be as minimally invasive as possible. Under the guidance, social media platforms will not have to verify the age of every user on their platforms. - คณะกรรมการ eSafety ของออสเตรเลียประกาศแนวทางบังคับใช้กฎหมายห้ามเด็กอายุต่ำกว่า 16 ปีเล่นโซเชียลมีเดีย ซึ่งจะมีผลวันที่ 10 ธันวาคมนี้ โดยยืนยันว่าต้องการลดผลกระทบต่อผู้ใช้ให้มากที่สุด ทั้งนี้ แพลตฟอร์มโซเชียลจะไม่ถูกบังคับให้ตรวจสอบอายุผู้ใช้ทุกราย
Another packed episode for this month's issue of the journal. There's a special emphasis on case reports this time, showing their value as a way to understand the rarely encountered. For the more common conditions there are guidelines, and the editors give you an introduction to the new ABN guidelines on myasthenia gravis, as a preview to an upcoming full episode on the topic. There's a birder's take on the use of EEG for status epilepticus, a review of the benefits and challenges for digital health records, and some deliberation on ophthalmological pronunciation. Plus, an opportunity to test your knowledge on illicit drug slang: do you know your "jeff" from your "khat"? Read the highlights: https://pn.bmj.com/content/25/5/391 Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production by Brian Kennedy, Letícia Amorim. Editing by Brian O'Toole. Thank you for listening.
Federal health officials have narrowed the recommendation for who should get a COVID vaccine. The committee that makes those decisions is meeting this week, and could make more changes. For now, insurance providers are still covering the costs for vaccinations.
Dr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated recommendations on topics including PMRT after upfront surgery, PMRT after neoadjuvant systemic therapy, dose and fractionation schedules, and delivery techniques. They comment on the importance of a multidisciplinary approach and providing personalized care based on individual patient characteristics. Finally, they review ongoing research that may impact these evidence-based guidelines in the future. Read the full guideline, “Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline” at www.asco.org/breast-cancer-guidelines" TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/breast-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-01747 Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I am interviewing Dr. Kathleen Horst, expert panel chair from Stanford University; Dr. Rachel Jimenez, expert panel vice chair from Massachusetts General Hospital; and Dr. Yara Abdou, ASCO representative from the University of North Carolina, authors on "Postmastectomy Radiation Therapy: An American Society for Radiation Oncology, American Society of Clinical Oncology, and Society of Surgical Oncology Clinical Practice Guideline." Thank you for being here today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Kathleen Horst: Thank you for having us. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Horst, Dr. Jimenez, and Dr. Abdou who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. Then to dive into the content that we are here today to talk about, Dr. Horst, could you start us off by describing what prompted the update for this joint guideline between ASTRO, ASCO, and SSO, and what is the scope of this 2025 guideline on postmastectomy radiation therapy? Dr. Kathleen Horst: Thank you. This joint guideline was last updated in 2016. Over the past decade, the treatment of breast cancer has evolved substantially. Newer systemic therapy regimens have increasingly personalized treatment based on tumor biology, and local therapy management has explored both the de-escalation of axillary surgery and more abbreviated courses of radiation therapy. Given these advances, it was important to revisit the role of postmastectomy radiotherapy in this modern era of breast cancer therapy. This updated guideline addresses four key questions, including postmastectomy radiation therapy after upfront surgery as well as after neoadjuvant systemic therapy. It also reviews the evolving role of various dose and fractionation schedules and optimal treatment techniques and dose constraints. Brittany Harvey: Excellent. I appreciate that background, Dr. Horst. So then, next, Dr. Jimenez, I would like to review the recommendations of this guideline across those four key questions that Dr. Horst just mentioned. So first, what does the panel recommend for PMRT for patients who received initial treatment with mastectomy? Dr. Rachel Jimenez: The panel provided pretty strong consensus that patients with positive lymph nodes or patients with large tumors involving the skin or the chest wall should receive postmastectomy radiation. However, the panel also recognized that the omission of postmastectomy radiation may be appropriate for select patients who have positive lymph nodes and have an axillary lymph node dissection if they have a low nodal burden and other favorable clinical or pathologic features. For patients without lymph node involvement at the time of surgery and no involvement of the skin or chest wall, postmastectomy radiation was not advised by the panel. Brittany Harvey: Understood. It is helpful to understand those recommendations for that patient population. Following that, Dr. Abdou, what are the key recommendations for PMRT for patients who received neoadjuvant systemic therapy before mastectomy? Dr. Yara Abdou: When we think about PMRT after neoadjuvant treatment, the key point is that the initial stage of presentation still matters a lot. So for example, if a patient comes in with more advanced disease, say a large primary tumor, like a clinical T4, or more extensive nodal disease, like an N2 or N3 disease, those patients should get PMRT, no matter how well they respond to neoadjuvant therapy, because we know it reduces the risk of recurrence and that has been shown pretty consistently. On the other hand, if there are still positive lymph nodes after neoadjuvant treatment, basically residual nodal disease, PMRT is also strongly recommended because the risk of local-regional recurrence is much higher in that setting. The gray area is the group of patients who start with a lower burden of nodal disease, such as N1 disease, but then become node negative at surgery. For those patients, we tend to individualize the decision. So if the patient is young or has triple-negative disease, or if there is a lot of residual disease in the breast even though the nodes are cleared, then radiation is probably helpful. But if everything has melted away with pCR in both the breast and the nodes, then it may be safe to omit PMRT in those patients. For patients with smaller tumors and no nodal involvement to begin with, like a clinical T1-T2 N0, if they are still node negative after neoadjuvant treatment, then PMRT is generally not recommended because their baseline recurrence risk is low. And finally, if the margins are positive and cannot be re-excised, then PMRT is recommended after neoadjuvant therapy. Brittany Harvey: Yes, those distinctions are important for appropriate patient selection. So then, Dr. Horst, we have just reviewed the indications for PMRT, but for those patients who receive PMRT, what are the appropriate treatment volumes and dose fractionation regimens? Dr. Kathleen Horst: The guideline addresses coverage of the chest wall and regional nodes with a specific discussion of the data regarding internal mammary nodal irradiation, which has been an area of controversy over many years. The guideline also reviews the data exploring moderate hypofractionation, or shorter courses of radiation therapy. The task force recommends utilizing moderate hypofractionation for the majority of women requiring postmastectomy radiation, which is likely to have a large impact on clinical practice. This recommendation is based on the evolving data demonstrating that a 3-week course of radiotherapy after mastectomy provides similar oncologic outcomes and minimal toxicity for most patients compared to the standard 5-week treatment course. Brittany Harvey: Thank you for reviewing that set of recommendations as well. So then, Dr. Jimenez, to wrap us up on the key questions here, what delivery techniques are recommended for treating patients who receive PMRT? Dr. Rachel Jimenez: So this portion of the guideline is likely to be most helpful for radiation oncologists because it represents the most technical part of the guideline, but we do believe that it offers some important guidance that has, to this point, been lacking in the postmastectomy radiation setting. So first, the panel recommends that all patients should undergo 3-dimensional radiation planning using CAT scan based imaging, and this includes contouring. So contouring refers to the explicit identification, using a drawing interface on the CAT scan imaging, by the radiation oncologist to identify the areas that are targeted to receive radiation, as well as all of the nearby normal tissues that could receive unintended radiation exposure. And we also provide radiation oncologists in the guideline with suggestions about how much dose each target tissue should receive and what the dose limits should be for normal tissues. Additionally, we make some recommendations regarding the manner in which radiation is delivered. So for example, we advise that when conventional radiation methods are not sufficient for covering the areas of the body that are still at risk for cancer, or where too high of a dose of radiation would be anticipated to a normal part of the body, that providers employ a technique called intensity modulated radiation therapy, or IMRT. And if IMRT is going to be used, we also advise regular 3-dimensional imaging assessments of the patient's body relative to the treatment machine to ensure treatment fidelity. When the treatments are delivered, we further advise using a deep inspiration breath-hold technique, which lowers the exposure to the heart and to the lungs when there is concern for cardiopulmonary radiation exposure, and again, that image guidance be used along with real-time monitoring of the patient's anatomy when those techniques are employed. And then finally, we advise that patients receiving postmastectomy radiation utilize a bolus, or a synthetic substance placed on the patient's skin to enhance radiation dose to the superficial tissue, only when there is involvement of the skin with cancer or other high-risk features of the cancer, but not for every patient who receives postmastectomy radiation. Brittany Harvey: Understood. And then, yes, you just mentioned that section of the guideline is probably most helpful for radiation oncologists, but I think you can all comment on this next question. What should all clinicians, including radiation oncologists, surgical oncologists, medical oncologists, and other oncologic professionals, know as they implement all of these updated recommendations? Dr. Rachel Jimenez: So I think one of the things that is most important when we consider postmastectomy radiation and making recommendations is that this is a multidisciplinary panel and that we would expect and encourage our colleagues, as they interpret the guidelines, to employ a multidisciplinary approach when they are discussing each individual patient with their surgical and medical oncology colleagues, that there is no one size fits all. So these guidelines are intended to provide some general guidance around the most appropriate techniques and approaches and recommendations for the utilization of postmastectomy radiation, but that we recognize that all of these recommendations should be individualized for patients and also represent somewhat of a moving target as additional studies, both in the surgical and radiation oncology realm as well as in the systemic therapy realm, enter our milieu, we have to adjust those recommendations accordingly. Dr. Kathleen Horst: Yeah, I would agree, and I wanted to comment as a radiation oncologist, we recognize that local-regional considerations are intertwined with systemic therapy considerations. So as the data evolve, it is critical to have these ongoing updates in a cross-disciplinary manner to ensure optimal care for our patients. And as Dr. Jimenez mentioned, these multidisciplinary discussions are critical for all of us to continue to learn and understand the evolving recommendations across disciplines but also to individualize them according to individual patients. Dr. Yara Abdou: I could not agree more. I think from a medical oncology perspective, systemic therapy has gotten much better with adjuvant CDK4/6 inhibitors, T-DM1, capecitabine, and immune therapy. So these are all newer adjuvant therapies, so the baseline recurrence risks are lower than what they were in the trials that established PMRT. So the absolute benefit of radiation varies more now, so smaller for favorable biology but still relevant in aggressive subtypes or with residual disease. So it is definitely not a one-size-fits-all. Brittany Harvey: Yes, I think it is important that you have all highlighted that multidisciplinary approach and having individualized, patient-centric care. So then, expanding on that just a little bit, Dr. Abdou, how will these guideline recommendations affect patients with breast cancer? Dr. Yara Abdou: So basically, reiterating what we just talked about, these guidelines really move us towards personalized care. So for patients at higher risk, so those with larger tumors, multiple positive nodes, or residual nodal disease after neoadjuvant therapy, PMRT remains essential, consistently lowering local-regional recurrence and improving survival. But for patients at intermediate or lower risk, the recommendations support a more selective approach. So instead of a blanket rule, we now integrate tumor biology, response to systemic therapy, and individual patient factors to decide when PMRT adds meaningful benefit. So the impact for patients is really important because those at high risk continue to get the survival advantage of radiation while others can be spared the unnecessary treatment and side effects. So in short, we are aligning PMRT with modern systemic therapy and biology, making sure each patient receives the right treatment for their situation. Brittany Harvey: Absolutely. Individualizing treatment to every patient will make sure that everyone can achieve the best outcomes as possible. So then, Dr. Jimenez, to wrap us up, I believe Dr. Horst mentioned earlier that data continues to evolve in this field. So in your opinion, what are the outstanding questions regarding the use of PMRT and what are you looking to for the future of research in this space? Dr. Rachel Jimenez: So there are a number of randomized phase III clinical trials that are either in active accrual or that have reported but not yet published that are exploring further de-escalation of postmastectomy radiation and of axillary surgery. And so we do not yet have sufficient data to understand how those two pieces of information integrate with each other. So for example, if you have a patient who has a positive lymph node at the time of diagnosis and forgoes axillary surgery aside from a sentinel lymph node biopsy, we do not yet know that we can also safely forgo radiation entirely in that setting. So we expect that future studies are going to address these questions and understand when it is appropriate to simultaneously de-escalate surgery and radiation. Additionally, there is a number of trials that are looking at ways in which radiation could be omitted or shortened. So there is the RT CHARM trial, which has reported but not yet published, looking at a shorter course of radiation. And so we do make recommendations around that shorter course of radiation in this guideline, but we anticipate that the additional data from the RT CHARM study will provide further evidence in support of that. Additionally, there is a study called the TAILOR RT trial, which looks at forgoing postmastectomy radiation in patients who, to Dr. Abdou's point, have a favorable tumor biology and a low 21-gene recurrence score. And so we are going to anticipate the results from that study to help guide who can selectively forgo postmastectomy radiation when they fall into that favorable risk category. So there are a number of questions that I think will help flesh out this guideline. And as they publish, we will likely publish a focused update on that information to help provide context for our colleagues in the field and clarify some of these recommendations to suit the latest data. Brittany Harvey: Absolutely. We will look forward to those de-escalation trials and ongoing research in the field to build on the evidence and look for future updates to this guideline. So I want to thank you for your work to update these guidelines, and thank you for your time today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Rachel Jimenez: Thank you. Dr. Yara Abdou: Thank you. Dr. Kathleen Horst: Thank you. Brittany Harvey: And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/breast-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
Australia's eSafety commissioner has published regulatory guidelines for social media platforms, giving effect to the government's under-16 social media ban. While the ban won't be in place until December 10th, the eSafety commissioner says they want it to be as minimally invasive as possible. Under the guidance, social media platforms will not have to verify the age of every user on their platforms.
Dr. Rick and Forrest explore how to use a life crisis productively, drawing on developmental stage theories, existential philosophy, literature, personal experience, and Rick's clinical work. They examine the anxieties of death, freedom, responsibility, and choice that often underlie these crises, and discuss how we can not only cope with these anxieties but also harness them to build a more authentic life. Throughout, they simplify, summarize, and invite you to focus on not just the next 10 years, but the next 10 minutes. Key Topics: 0:00: Introduction 5:26: Life Stages: Erickson and Levinson 15:34: Healthy vs. Unhealthy Discontent 17:18: Inner Conflict and the Anxiety of Choice 24:18: Guidelines for Having a “Good Life Crisis” 29:36: Seizing Each Day 33:00: Coping with the Anxiety of Choice 35:17: Authenticity, Values, and Living True to Yourself 44:17: Roles and Life Transitions 46:28: Clarifying Your Values 52:09: Taking Action 57:28: Recap Support the Podcast: We're now on Patreon! If you'd like to support the podcast, follow this link. Sponsors If you are exploring whether you might be neurodivergent, check out Hyperfocus with Rae Jacobson. Level up your bedding with Quince. Go to Quince.com/BEINGWELL for free shipping on your order and three hundred and sixty-five -day returns. Join hundreds of thousands of people who are taking charge of their health. Learn more and join Function at functionhealth.com/BEINGWELL. Listen now to the Life Kit podcast from NPR. Go to Zocdoc.com/BEING to find and instantly book a top-rated doctor today. Sign up for a one-dollar-per-month trial period at shopify.com/beingwell. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, I discuss with researcher and associate professor at the University of Alberta, Dr Margie Davenport: 2019 Canadian guideline for physical activity throughout pregnancyThe benefits of physical activity following childbirthThe recommendations for how much activity and the importance of gradual progressionDo we actually need to wait 6 weeks to do exercise postpartum?Do we all NEED clearance from our care provider to exercise?The impact of sleep and breastfeeding No two people are the same! Dr. Davenport was the Chair of the 2019 Canadian Guideline for Physical Activity throughout Pregnancy, and the 2025 Canadian Guideline for Physical Activity, Sedentary Behaviour and Sleep throughout the First Year Postpartum. This work led to the development of the Get Active Questionnaire for Pregnancy, Get Active Questionnaire for Postpartum and the Canadian Society for Exercise Physiology/American College of Sports Medicine Pre & Postnatal Exercise Specialization. Dr. Davenport leads the Program for Pregnancy and Postpartum Health (www.exerciseandpregnancy.ca), and has published more than 200 manuscripts related to physical activity and sport during preconception, pregnancy and the postpartum period. Over the last decade she has worked with a number of National/International organizations including FIFA, the World Health Organization, International Olympic Committee, Sport Canada, the Canadian Society for Exercise Physiology, and the American College of Sports Medicine to support physical activity during and following pregnancy. LINKS MENTIONED2019 Canadian Physical Activity Guidelines throughout Pregnancy 2025 Canadian Guideline for Physical Activity, Sedentary Behaviour & Sleep Throughout the First Year Postpartum.New Screening Tool: Get Active Questionnaire for PostpartumTHANK YOU TO THE EPISODE SPONSORSRC Health: discount code and website: https://srchealth.com/?ref=Sto_l3PawmnH4. Discount Code: THEPELVICFLOORPROJECTIRIS: discount code and website: https://www.lovemyiris.com/ Discount Code: PELVICFLOORPROJECTThanks for joining me! Here is where you can find out how to work with me: www.pelvicfloorprojectspace.com/mel@pelvicfloorprojectspace.comSupport the show
For many women over 40, cardio brings up memories of the 90s and early 2000s—endless hours on the elliptical, chasing a smaller body, and pushing through with Red Bulls and salads. It was an era marked by toxic fitness culture, and the fallout left a lot of us burnt out, swearing off cardio completely. But now, with energy, stamina, and health markers changing in midlife, it might be time to take another look at how cardio fits into your life. In this episode, we explore what it means to rebuild a healthier relationship with cardio. From my personal journey—burnout from endurance sports, swinging the pendulum into strength training, then finding my way back to cardio on my own terms—to practical ways you can ease it back into your routine, this conversation is about healing from old patterns and creating balance. You'll also hear answers to common questions about what counts as cardio, how to tell if it's moderate or vigorous, and how to weave it in with your lifting. What you'll learn in this episode: Why so many women over 40 have a complicated history with cardio The role of diet culture and body ideals in shaping our relationship with endurance exercise How to reframe cardio as a supportive tool instead of punishment Practical ways to bring conditioning back without burnout or dread Guidelines for balancing cardio with strength training so both work together Simple strategies for starting small and progressing over time Enjoyed this episode and want more? If you want a lifting program that tells you exactly what to do, try 7 days of Strong with Steph here >> https://stephgaudreau.com/workout Share this episode with a friend looking to improve their strength training knowledge. Subscribe to this podcast on your favorite streaming platform for new episodes!
Your talent deserves more than a paycheck. It deserves the right environment where you're noticed, valued, and set up to grow. Here's how to find it.
© 2020-2025 Ivy Podcast Discovery LLC
